T细胞代谢重编程在复发性流产中的研究进展

张欣 ,  李雪冰 ,  王春霞

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (10) : 945 -948.

PDF (403KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (10) : 945 -948. DOI: 10.12007/j.issn.0258‐4646.2026.10.014
综述

T细胞代谢重编程在复发性流产中的研究进展

作者信息 +

Research progress on T cell metabolic reprogramming in recurrent spontaneous abortion

Author information +
文章历史 +
PDF (412K)

摘要

复发性流产 (RSA) 病因复杂,涉及遗传、解剖、内分泌、感染、环境及免疫等多种因素。母胎界面免疫失衡是RSA的重要机制,T细胞功能异常与其密切相关。糖代谢、氨基酸代谢和脂质代谢重编程可改变T细胞增殖、分化和效应功能,进而影响Th17/Treg、Th1/Th2细胞平衡,破坏妊娠免疫耐受。mTOR、AMPK和GCN2等信号通路在上述过程中发挥关键调控作用。本文对T细胞代谢重编程在RSA中的研究进展进行综述,并探讨基于代谢调控的免疫治疗思路,以期为RSA机制研究和治疗策略提供参考。

Abstract

Recurrent spontaneous abortion (RSA) has a multifactorial etiology involving genetic,anatomical,endocrine,infectious,envi ronmental,and immunological factors. Immune imbalance at the maternal-fetal interface is a key mechanism underlying RSA,and T cell dysfunction is closely associated with this process. Reprogramming of glucose,amino acid,and lipid metabolism reshapes T cell prolife- ration,differentiation,and effector function,thereby disturbing the helper T (Th) 17/regulatory T (Treg) cell and Th1/Th2 cell balance and weakening maternal-fetal immune tolerance. Signaling pathways such as mTOR,AMPK,and GCN2 are central regulators of these metabo- lic-immune interactions. This review summarizes recent evidence regarding T cell metabolic reprogramming in RSA and discusses immu notherapeutic strategies based on metabolic regulation,thereby providing a reference for mechanistic studies and treatment development.

关键词

复发性流产 / T细胞 / 代谢重编程 / 免疫治疗

Key words

recurrent spontaneous abortion / T cell / metabolic reprogramming / immunotherapy

引用本文

引用格式 ▾
张欣,李雪冰,王春霞. T细胞代谢重编程在复发性流产中的研究进展[J]. 中国医科大学学报, 2026, 55(10): 945-948 DOI:10.12007/j.issn.0258‐4646.2026.10.014

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

ESHRE guideline group on RPL, Bender Atik R,Christiansen O B,et al. ESHRE guideline:recurrent pregnancy loss:an update in 2022 [J]. Hum Reprod Open,2023,2023 (1):hoad002. DOI:10.1093/hropen/hoad002.

[2]

中华医学会妇产科学分会产科学组,复发性流产诊治专家共识编写组. 复发性流产诊治专家共识 (2022) [J]. 中华妇产科杂志, 2022,57 (9):653-667. DOI:10.3760/cma.j.cn112141-20220421-00259.

[3]

Ganer Herman H,Volodarsky-Perel A,Nu T N T,et al. Does a history of recurrent pregnancy loss affect subsequent obstetric outcomes and placental findings in in vitro fertilization? [J]. J Assist Reprod Genet, 2022,39 (12):2711-2718. DOI:10.1007/s10815-022-02644-4.

[4]

Iordăchescu D A,Paica C I,Boca A E,et al. Anxiety,difficulties,and coping of infertile women [J]. Healthcare (Basel),2021,9 (4):466. DOI:10.3390/healthcare9040466.

[5]

Kelley E L,Kingsberg S A. Sexuality and infertility [J]. Obstet Gynecol Clin North Am,2024,51 (2):311-322. DOI:10.1016/j.ogc.2024.02.005

[6]

Holt-Kentwell A,Ghosh J,Devall A,et al. Evaluating interventions and adjuncts to optimize pregnancy outcomes in subfertile women: an overview review [J]. Hum Reprod Update,2022,28 (4):583-600. DOI:10.1093/humupd/dmac001.

[7]

Yao Y,Ye Y Q,Chen J,et al. Maternal-fetal immunity and recurrent spontaneous abortion [J]. Am J Reprod Immunol,2024,91 (5):e13859. DOI:10.1111/aji.13859.

[8]

Weng J,Couture C,Girard S. Innate and adaptive immune systems in physiological and pathological pregnancy [J]. Biology,2023,12 (3):402. DOI:10.3390/biology12030402.

[9]

Li Y,Chen S X,Yang J C,et al. Associations of Th1,Th2,Th17,and Treg cell levels and imbalance with recurrent spontaneous abortion: a meta-analysis [J]. J Obstet Gynaecol Res,2025,51 (1):e16207. DOI:10.1111/jog.16207.

[10]

Liu H M,Huang W R,Hu Z Y,et al. Regulatory T cells in human pregnancy:mechanisms,dysregulation,and therapeutic perspec tives [J]. Front Immunol,2026,17:1815957. DOI:10.3389/fimmu.2026.1815957.

[11]

Lu Y M,Wang Y F,Ruan T T,et al. Immunometabolism of Tregs: mechanisms,adaptability,and therapeutic implications in diseases [J]. Front Immunol,2025,16:1536020. DOI:10.3389/fimmu.2025.1536020.

[12]

Wang Z Z,Xu Z,Zong M,et al. Metabolic regulation of Th17 and Treg cell balance by the mTOR signaling [J]. Metab Open,2025, 26:100369. DOI:10.1016/j.metop.2025.100369.

[13]

Smith L C,Ramar M,Riley G L,et al. Steroid hormone regulation of immunometabolism and inflammation [J]. Front Immunol,2025,16:1654034. DOI:10.3389/fimmu.2025.1654034.

[14]

Quinn W J,Jiao J,TeSlaa T,et al. Lactate limits T cell proli- feration via the NAD (H) redox state [J]. Cell Rep,2020,33 (11):108500. DOI:10.1016/j.celrep.2020.108500.

[15]

Mensink M,Tran T N M,Zaal E A,et al. TNFR2 costimulation differentially impacts regulatory and conventional CD4+ T-cell me tabolism [J]. Front Immunol,2022,13:881166. DOI:10.3389/fimmu.2022.881166.

[16]

Giugliano S,Gatti A,Rusin M,et al. Maternal gut microbiota in fluences immune activation at the maternal-fetal interface affecting pregnancy outcome [J]. Nat Commun,2025,16:4326. DOI:10.1038/s41467-025-58533-8.

[17]

Shi Y M,Tang X F. From gut dysbiosis to decidual hostility:the im muno-metabolic crosstalk driving recurrent pregnancy loss [J]. Front Immunol,2025,16:1746620. DOI:10.3389/fimmu.2025.1746620.

[18]

Chen Y H,Gan B,Zheng S,et al. AMPK-mTOR pathway modulates glycolysis reprogramming in unexplained recurrent spontaneous abortion [J]. BMC Pregnancy Childbirth,2024,24 (1):840. DOI:10.1186/s12884-024-07054-1.

[19]

Xu M Y,Zhang C L,Wu D,et al. Th17/treg cell imbalance may contribute to spontaneous preterm labor [J]. J Immunol Res,2025, 2025:8405365. DOI:10.1155/jimr/8405365.

[20]

Braga A,Neves E,Guimarães J,et al. Th17/Regulatory T cells ratio evolution:a prospective study in a group of healthy pregnant women [J]. J Reprod Immunol,2022,149:103468. DOI:10.1016/j.jri.2021.103468.

[21]

Ding N,Yang X,Wang R F,et al. Metabolomics profiling identifies diagnostic metabolic signatures for pregnancy loss:a cross-sectional study from northwestern China [J]. Front Endocrinol,2025,16:1518043. DOI:10.3389/fendo.2025.1518043.

[22]

Qin D K,Chen Z C,Deng X J,et al. CD24+ decidual stromal cells: a novel heterogeneous population with impaired regulatory T cell induction and potential association with recurrent miscarriage [J]. Fertil Steril,2024,121 (3):519-530. DOI:10.1016/j.fertnstert.2023.11.025.

[23]

Wetzel T J,Erfan S C,Figueroa L D,et al. Crosstalk between argi nine,glutamine,and the branched chain amino acid metabolism in the tumor microenvironment [J]. Front Oncol,2023,13:1186539. DOI:10.3389/fonc.2023.1186539.

[24]

Shi Y X,Zhang H,Miao C H. Metabolic reprogram and T cell diffe- rentiation in inflammation:current evidence and future perspectives [J]. Cell Death Discov,2025,11:123. DOI:10.1038/s41420-025-02403-1.

[25]

Jin H O,Hong S E,Kim J Y,et al. Amino acid deprivation in duces AKT activation by inducing GCN2/ATF4/REDD1 axis [J]. Cell Death Dis,2021,12 (12):1127. DOI:10.1038/s41419-021-04417-w.

[26]

Sittig S P,van Beek J J P,Flórez-Grau G,et al. Human type 1 and type 2 conventional dendritic cells express indoleamine 2,3-dioxy genase 1 with functional effects on T cell priming [J]. Eur J Immu nol,2021,51 (6):1494-1504. DOI:10.1002/eji.202048580.

[27]

Park J S,Song A Y,Bae J Y,et al. IL-17 producing T to Foxp3+CD4+ regulatory T cell ratio as a diagnostic and prognostic marker in wom en with recurrent pregnancy loss and its implications for intravenous immunoglobulin therapy [J]. Am J Reprod Immunol,2024,92 (5):e70020. DOI:10.1111/aji.70020.

[28]

Tang C,Hu W Q. The role of Th17 and Treg cells in normal preg nancy and unexplained recurrent spontaneous abortion (URSA): new insights into immune mechanisms [J]. Placenta,2023,142:18-26. DOI:10.1016/j.placenta.2023.08.065.

[29]

Thiele K,Urbschat C,Riquelme J I A,et al. Pregnancy-acquired memory CD4+ regulatory T cells improve pregnancy outcome in mice [J]. Nat Commun,2025,16 (1):6522. DOI:10.1038/s41467-025-61572-w.

[30]

Zhang L,Wang Z W,Wu H H,et al. Maternal high-fat diet im pairs placental fatty acid β-oxidation and metabolic homeostasis in the offspring [J]. Front Nutr,2022,9:849684. DOI:10.3389/fnut.2022.849684.

[31]

Lim S A,Su W,Chapman N M,et al. Lipid metabolism in T cell signaling and function [J]. Nat Chem Biol,2022,18 (5):470-481. DOI:10.1038/s41589-022-01017-3.

[32]

Guan D F,Sun W J,Gao M X,et al. Immunologic insights in recur rent spontaneous abortion:molecular mechanisms and therapeutic interventions [J]. Biomed Pharmacother,2024,177:117082. DOI:10.1016/j.biopha.2024.117082.

[33]

南文慧,秦训思,李蓉. 脂质代谢失衡:复发性流产的潜在病理机 制与干预新思路 [J]. 遗传,2025,47 (9):979-991. DOI:10.16288/j.yczz.24-332.

[34]

Wagner A,Wang C,Fessler J,et al. Metabolic modeling of single Th17 cells reveals regulators of autoimmunity [J]. Cell,2021,184 (16):4168-4185.e21. DOI:10.1016/j.cell.2021.05.045.

[35]

Volland J M,Kaupp J,Schmitz W,et al. Mass spectrometric meta bolic fingerprinting of 2-deoxy-D-glucose (2-DG) -induced inhibition of glycolysis and comparative analysis of methionine restriction ver sus glucose restriction under perfusion culture in the murine L929 model system [J]. Int J Mol Sci,2022,23 (16):9220. DOI:10.3390/ijms23169220.

[36]

Su M,Shan S D,Gao Y,et al. 2-deoxy-D-glucose simultaneously tar gets glycolysis and Wnt/β-catenin signaling to inhibit cervical cancer progression [J]. IUBMB Life,2023,75 (7):609-623. DOI:10.1002/iub.2706.

[37]

Kumar D,Nguyen T H,Bennett C M,et al. mTOR inhibition attenua- tes cTfh cell dysregulation and chronic T-cell activation in multili- neage immune cytopenias [J]. Blood,2023,141 (3):238-243. DOI:10.1182/blood.2022015966.

[38]

Han J W,Park J S,Kim J S,et al. Efficacy of intravenous immuno globulin in recurrent pregnancy loss:a retrospective analysis of pa tients with abnormal cellular immunity [J]. Front Endocrinol,2025, 16:1546602. DOI:10.3389/fendo.2025.1546602.

基金资助

吴阶平医学基金科研专项(320.6750.2024-03-70)

AI Summary AI Mindmap
PDF (403KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉